S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

NASDAQ:MRNSMarinus Pharmaceuticals SEC Filings & 10K Form

$1.66
+0.01 (+0.61 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.56
Now: $1.66
$1.75
50-Day Range
$1.19
MA: $2.09
$3.04
52-Week Range
$0.77
Now: $1.66
$5.40
Volume970,835 shs
Average Volume1.14 million shs
Market Capitalization$136.57 million
P/E RatioN/A
Dividend YieldN/A
Beta2.47

SEC Filings

Marinus Pharmaceuticals (NASDAQ:MRNS) SEC Filings

DateFilerForm TypeView
03/02/2020
8:01 AM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
02/14/2020
2:19 PM
Lion Point Capital, LP (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
02/14/2020
5:27 AM
Bain Capital Life Sciences Fund, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
9:38 AM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2020
2:05 PM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
02/03/2020
5:29 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:59 PM
Granite Point Capital Management, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
01/10/2020
3:54 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:53 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:53 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:52 PM
Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:52 PM
Carrazana Enrique J. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:52 PM
DOUGHERTY MICHAEL R (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:51 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
12:59 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
12/13/2019
4:12 PM
Boxer Capital, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
12/13/2019
3:16 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2019
3:08 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:06 PM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:05 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/11/2019
11:09 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
4:22 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/09/2019
6:18 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
5:56 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2019
3:03 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:01 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2019
12:31 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
3:00 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
3:05 PM
Marinus Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
09/26/2019
11:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:05 PM
Lorianne Masuoka K. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
3:05 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:34 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:32 PM
Marinus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
3:02 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2019
3:33 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
3:20 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:02 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:59 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
4:01 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/26/2019
4:23 PM
Marinus Pharmaceuticals (Filer)
Form DEFA14A
03/25/2019
4:06 PM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
03/20/2019
4:57 PM
Cashman Christopher Michael (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
3:03 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
3:04 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
4:04 PM
Marinus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2019
11:06 AM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/28/2019
6:00 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
6:00 PM
Lorianne Masuoka K. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:59 PM
DOUGHERTY MICHAEL R (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:59 PM
Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:58 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:58 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:57 PM
Carrazana Enrique J. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
4:21 PM
Marinus Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
4:11 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
10:06 AM
Bain Capital Life Sciences Fund, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/01/2019
11:02 AM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/01/2019
10:58 AM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
01/30/2019
3:09 PM
Cashman Christopher Michael (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
3:08 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
11:26 AM
Granite Point Capital Management, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
12/14/2018
4:03 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
4:19 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/11/2018
3:40 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/10/2018
6:35 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2018
3:05 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
3:05 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:01 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
3:04 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/20/2018
3:05 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2018
3:05 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
4:24 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
8:08 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
8:05 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2018
3:15 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2018
8:17 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2018
8:03 PM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
02/14/2018
12:50 PM
EcoR1 Capital, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2018
7:57 AM
Flynn James E (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
11:37 AM
Marinus Pharmaceuticals (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G/A
02/05/2018
2:36 PM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
01/29/2018
7:03 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4/A
01/29/2018
7:03 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4/A
01/29/2018
7:02 PM
Carrazana Enrique J. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4/A
01/29/2018
7:02 PM
Carrazana Enrique J. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4/A
01/29/2018
7:01 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4/A
01/29/2018
7:00 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2018
7:00 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4/A
01/24/2018
3:09 PM
Marinus Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2018
7:44 PM
Cashman Christopher Michael (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4/A
01/22/2018
7:41 PM
Cashman Christopher Michael (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2018
7:38 PM
Cashman Christopher Michael (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4/A
01/22/2018
7:54 AM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G
01/11/2018
12:03 PM
Granite Point Capital Management, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
01/10/2018
11:57 AM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
12/19/2017
7:30 PM
Bain Capital Life Sciences Fund, L.P. (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
Bain Capital Life Sciences Partners, LP (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
Koppel Adam (Reporting)
Marinus Pharmaceuticals (Issuer)
Schwartz Jeffrey Lawrence (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2017
4:16 PM
Bain Capital Life Sciences Fund, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
12/08/2017
3:19 PM
Marinus Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2017
3:06 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel